Sequent Scientific Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Sequent Scientific Limited generated cash of $305,950,000, which is more than the previous year. Cash used in financing activities reached the amount of $45,460,000 last year. Net change in cash is therefore $232,360,000.
Cash Flow
| 2010 | 168.95M | -40.58M | -59.49M |
|---|---|---|---|
| 2011 | 506.6M | -717.66M | 165.11M |
| 2012 | 302.36M | -667.83M | 619.35M |
| 2016 | -510K | -3.15B | 3.08B |
| 2018 | 452.39M | 71.68M | -569.59M |
| 2020 | 1.15B | -722.7M | -427.53M |
| 2021 | 1.14B | 96.48M | -1.38B |
| 2023 | 168.08M | -649.58M | 322.28M |
| 2024 | 305.95M | -119.05M | 45.46M |
SEQUENT.NS Cash Flow Statement (2010 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | 2015 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 415.74M | 574.96M | 680.96M | 677.89M | 440.96M | 218.31M | 91.71M | 140.68M | 41.03M |
Operating activities | |||||||||
Net income | -358.69M | -1.37B | 1.45B | 940.75M | 4.45B | -169.64M | -13.99M | -1.76M | 374.17M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 615.4M | 556.93M | 505.98M | 506.22M | 532.97M | 482.31M | 229.81M | 206.9M | 239.1M |
Stock-based compensation expense | 222.28M | 354.11M | 72.34M | 46.67M | 33.31M | 56.05M | 0 | 0 | 0 |
| Deferred income tax benefit | 222.28M | 354.11M | 72.34M | 46.67M | 33.31M | 56.05M | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | -87.82M | -412.64M | -394.75M | -508.17M | -668.77M | -328.51M | 0 | 0 | 0 |
Inventories | 2.86M | 50.79M | -456.17M | -193.14M | -584.73M | -68.41M | -46.86M | -143.17M | -177.76M |
Accounts payable | -371.36M | -170.13M | 89.29M | 153.13M | 463.8M | -366.59M | 0 | 0 | 0 |
Cash generated by operating activities | 305.95M | 168.08M | 1.14B | 1.15B | 452.39M | -510K | 302.36M | 506.6M | 168.95M |
Investing activities | |||||||||
Purchases Of Investments | -82.23M | -83.16M | -1.40B | -390.07M | 0 | -2.37B | 840K | -1.7M | 275.15M |
Investments In Property Plant And Equipment | -308.07M | -861.79M | -528.3M | -407.22M | -470.22M | -655.38M | -818.66M | -584.73M | -249.31M |
Acquisitions Net | 191.52M | -154.4M | -1.40B | 389.7M | -19.14M | -1.37B | 0 | 0 | 0 |
Cash generated by investing activities | -119.05M | -649.58M | 96.48M | -722.7M | 71.68M | -3.15B | -667.83M | -717.66M | -40.58M |
Financing activities | |||||||||
Common Stock Issued | 0 | 0 | 104.49M | 20.99M | 7.13M | 5.53B | 46.5M | 8.82M | 8.54M |
Payments for dividends | 0 | 0 | 0 | -58.26M | -48.46M | 0 | -32.9M | -42.47M | -11.09M |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 548.07M | 123.49M | -1.61B | -67.72M | -506.56M | -293.2M | 0 | 0 | 0 |
Cash used in financing activities | 45.46M | 322.28M | -1.38B | -427.53M | -569.59M | 3.08B | 619.35M | 165.11M | -59.49M |
Net Change In Cash | 232.36M | -159.22M | -143.52M | 3.07M | -45.52M | -18.18M | 267.08M | -38.72M | 99.65M |
Cash at end of period | 648.1M | 415.74M | 537.44M | 680.96M | 395.44M | 200.13M | 358.79M | 101.96M | 140.68M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |